BioCentury – ENYO aims for Phase II HBV, NASH trials with €40m round

https://www.biocentury.com/bc-extra/financial-news/2018-06-04/enyo-aims-phase-ii-hbv-nash-trials-%E2%82%AC40m-round

Read next in 'Media coverage'